Bibliographic Details
Title: |
Deubiquitinase MYSM1 promotes doxorubicin-induced cardiotoxicity by mediating TRIM21-ferroptosis axis in cardiomyocytes. |
Authors: |
Shi, Xiaowen1 (AUTHOR), Xu, Jianjiang1 (AUTHOR), Zhong, Xin1 (AUTHOR), Qian, Yuanyuan2 (AUTHOR), Lin, Liming3 (AUTHOR), Fang, Zimin4 (AUTHOR), Ye, Bozhi3 (AUTHOR), Lyu, Yiting1 (AUTHOR), Zhang, Ran1 (AUTHOR), Zheng, Zhanxiong1 (AUTHOR) zhengzhanxiongjx2y@163.com, Han, Jibo1 (AUTHOR) jibohanjx2y@163.com |
Source: |
Cell Communication & Signaling. 12/18/2024, Vol. 22 Issue 1, p1-16. 16p. |
Subject Terms: |
*DEUBIQUITINATING enzymes, *CARDIOTOXICITY, *PROTEIN stability, *RNA sequencing, *ANTINEOPLASTIC agents, *DOXORUBICIN |
Abstract: |
Anthracycline antitumor drug doxorubicin (DOX) induces severe cardiotoxicity. Deubiquitinating enzymes (DUBs) are crucial for protein stability and function and play a significant role in cardiac pathophysiology. By comparing RNA sequencing datasets and conducting functional screening, we determined that Myb-like, SWIRM, and MPN domains 1 (MYSM1) is a key regulator of DOX-induced cardiotoxicity. In this study, we aimed to explore the function and regulatory mechanisms of MYSM1 in DOX-induced cardiotoxicity. Genetic knockdown of MYSM1 significantly mitigated DOX-induced cardiomyopathy. Correspondingly, cardiomyocyte-specific knockdown of MYSM1 by AAV9 protected the heart from DOX-induced cardiotoxicity. Gain- and loss-of-function analysis verified that MYSM1 mediated DOX-induced cardiomyocyte injury in vitro. Through a Co-IP combined with LC-MS/MS analysis, we discovered that MYSM1 directly interacted with tripartite motif-containing protein 21 (TRIM21). Mechanistic investigations revealed that MYSM1 regulates the deubiquitination and the stability of TRIM21 via its MPN domain. Furthermore, MYSM1 exacerbated DOX-induced cardiotoxicity by enhancing ferroptosis. This study identified MYSM1 as a potential therapeutic target for DOX-induced cardiotoxicity and illustrated a MYSM1-TRIM21-ferroptosis axis in regulating DOX-induced cardiotoxicity. [ABSTRACT FROM AUTHOR] |
|
Copyright of Cell Communication & Signaling is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
Database: |
Academic Search Complete |
Full text is not displayed to guests. |
Login for full access.
|